SOPHiA Genetics is the creator of a global data pooling and knowledge-sharing platform that advances data-driven medicine, working with customers from more than 780 institutions in more than 70 countries. The goal of this data-driven medicinal network is to improve health outcomes and economics worldwide. On July 22, SOPHiA Genetics announced the pricing of its initial public offering (Nasdaq: SOPH) of 13 million ordinary shares at $18 per share . . .
Home Information Management Data Analysis Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine

- Information Management
- Data Analysis
- Data Management
- GEN Edge
- Molecular Diagnostics/In vitro Diagnostics
- Sequencing
- Next-Generation Sequencing
- OMICs
- Precision Medicine
Creating a Clinical Crystal Ball: SOPHiA Genetics is Democratizing Data-Driven Medicine
CEO Jurgi Camblong discusses the international company’s platform that enables healthcare professionals to leverage their expertise and work together across the world.
SOPHiA Genetics CEO Jurgi Camblong, PhD, says the company is about halfway through its mission of connecting 780 hospitals around the world in 72 countries: "This speaks to our view of the world and on the democratization of these approaches." [SOPHiA Genetics]